Format

Send to

Choose Destination
J Occup Rehabil. 2012 Mar;22(1):51-8. doi: 10.1007/s10926-011-9320-6.

Validation of the PHQ-15 for somatoform disorder in the occupational health care setting.

Author information

1
Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands. l.vroege@trimbos.nl

Erratum in

  • J Occup Rehabil. 2012 Dec;22(4):590.

Abstract

INTRODUCTION:

Within the occupational health setting, somatoform disorders are a frequent cause of sick leave. Few validated screening questionnaires for these disorders are available. The aim of this study is to validate the PHQ-15 in this setting.

METHODS:

In a cross-sectional study of 236 sicklisted employees, we studied the performance of the PHQ-15 in comparison with the Mini International Neuropsychiatric Interview (MINI) as golden reference standard. We approached employees who were sick listed for a period longer than 6 weeks and shorter than 2 years for participation. This study was conducted on one location of a large occupation health service in the Netherlands, serving companies with more than 500 employees. All employees who returned the PHQ-15 were invited for the MINI interview. Specificity and sensitivity were calculated for optimal cut point and a receiver operating characteristic (ROC) was constructed.

RESULTS:

A total of 107 participants consented to participate in the MINI interview. A non-response analysis showed no significant differences between groups. According to the MINI, the prevalence of somatoform disorders was 21.5%, and the most frequent found disorder was a pain disorder. The PHQ-15 had an optimal cut point of 9 (patients scoring 9 or higher (≥9) were most likely to suffer from a somatoform disorder), with specificity and sensitivity equal to 61.9 and 56.5%, respectively. ROCs showed an area under the curve (AUC) of 0.63.

CONCLUSION:

The PHQ-15 shows moderate sensitivity but limited efficiency with a cut point of 9 and can be a useful questionnaire in the occupational health setting.

PMID:
21785907
PMCID:
PMC3274689
DOI:
10.1007/s10926-011-9320-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center